2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z

U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors

C. Bhati, I. Tzvetanov, R. Garcia-Roca, J. Oberholzer, E. Benedetti, H. Jeon.
U.S. Population Characteristics Impacting Rates of Organ Donation

B. Schleich,¹ S. Yoon,¹ M. Khasawneh,¹ K. Srihari,¹ W. Tajik,² H. Irving.²
Umbilical Vein Catheter Versus Double J Stent for Ureteric Anastomosis in Renal Transplantation: A Single Centre, Open Label, Randomized Trial

V. Swaroop, A. Pereira, S. Smith, O. Masood, R. Pararajasingam, T. Augustine, H. Riad, S. Mehra, A. Tavakoli.
Unknown Urological Pathologies in Renal Allografts from Deceased Donors. Should Image Evaluation Be Routinely Performed?

K. Yamaçake, W. Nahas, I. Antonopoulos, H. Kanashiro, R. Kato, A. Bull, R. Falci, A. Piovesan.
UNOS KDPI Score Is Significantly Overestimated for Pediatric En-Bloc Kidneys

L. Preczewski, K. Howes, N. Iovenette, A. Needham, B. Gallay.
Unrecognized Synchronous Hepatocellcular Carcinoma Lesions in Explanted Liver Transplant Specimens

D. Aufhauser, Jr.,¹ K. Eddinger,¹ E. Furth,² P. Abt,¹ M. Levine.¹
Upregulation of Heart Transplant IL-33 Is Critical in Cardiac Tissue Repair

Q. Liu, L. Mathews, J. Lott, B. Matta, H. Turnquist.
Ureteral Length in Living Donor Kidney Transplantation; Does Size Matter?

L. Ooms, I. Slagt, J. IJzermans, T. Terkivatan.
Urinary Cell-Free DNA Is a Sensitive Marker of Early Renal Transplant Injury

T. Sigdel, T. Tran, S.-C. Hsieh, M. Sarwal.
Urinary CXCL10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection

M. Rabant,^1,2 L. Amrouche,^2,3 X. Lebreton,³ F. Aulagnon,³ A. Benon,² V. Sauvaget,² R. Bonifay,² L. Morin,³ A. Scemla,³ M. Delville,³ F. Martinez,³ M. Timsit,⁴ J. Duong Van Huyen,¹ C. Legendre,³ F. Terzi,² D. Anglicheau.^2,3
Use of MELD Exception Points in Patients With Hepatic Neuroendocrine Tumor Metastases: Variable Use and Proposed Criterion for Approval

Y. Nobel,¹ D. Goldberg.^2,3,4
Use of RNA Sequencing for Discovery of Markers of Accommodation in Surveillance Biopsies from Recipients of an ABO-Incompatible Renal Transplant

A. McLean,² K. Dominy,¹ A. Sosinsky,¹ M. Mueller,¹ J. Galliford,² T. Cook,^1,2 C. Roufosse.^1,2
Use of Tissue Plasminogen Activator (TPA) in Liver Transplantation from Donation After Cardiac Death (DCD) Donors: A Controlled Randomized Trial

B. Eghtesad, K. Hashimoto, M. Watson, M. Nazzal, C. Quintini, D. Kelly, T. Diago, N. Kawamura, G. El-Gazzaz, M. Fujiki, F. Aucejo, C. Winans, C. Miller, J. Fung.
Utility and Outcomes of Expanded Screening Among Live Solid Organ Donors

A. Rosen, B. Ho, M. Ison.
Utility of Anti-Phospholipase A2 Receptor (Anti-PLA2R) ELISA Testing in Predicting Post-Transplant Idiopathic Membranous Nephropathy (IMN)

C. VanBeek,¹ D. Thomas,² A. Jimenez,² A. Vo,² S. Jordan,² M. Toyoda.²
Utilization and Characteristics of Kidney Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 B. Ho,² J. Leventhal,² D. Ladner.²
Utilization and Characteristics of Liver Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 M. Abecassis,² D. Ladner.²
Utilization and Characteristics of Pancreas and Simultaneous Kidney-Pancreas Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 B. Ho,² J. Leventhal,² D. Ladner.²
Utilization of Increased Risk Donors in a Canadian Multi-Organ Transplant Program

K. Doucette,¹ K. Worton,² J. Kutsogiannis,² J. Preiksaitis.¹
Utilization of Kidneys from Deceased Donors With Acute Kidney Injury

M. Aull, S. Sultan, J. Kim, A. Watkins, D. Dadhania, S. Kapur.
Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report

M. Asolati,¹ C. Kulig,² B. Bilir,² T. Pillen,¹ P. Gauthier,² B. Bista,² T. Heffron.¹
Utilization of Medicare Part D Among Transplant Recipients

M. Chisholm-Burns, C. Spivey.
Utilizing CDC High Risk Donors to Improve Outcomes in Liver Transplantation

V. Fleetwood, J. Lusciks, M. Hertl, E. Chan.

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z